[go: up one dir, main page]

MA29076B1 - Préparations pharmaceutiques comprenant un dérivé de camptothécine - Google Patents

Préparations pharmaceutiques comprenant un dérivé de camptothécine

Info

Publication number
MA29076B1
MA29076B1 MA29925A MA29925A MA29076B1 MA 29076 B1 MA29076 B1 MA 29076B1 MA 29925 A MA29925 A MA 29925A MA 29925 A MA29925 A MA 29925A MA 29076 B1 MA29076 B1 MA 29076B1
Authority
MA
Morocco
Prior art keywords
pharmaceutical preparations
camptothecin derivative
camptothecin
derivative
preparations
Prior art date
Application number
MA29925A
Other languages
English (en)
Inventor
Isabel Ottinger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35691476&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29076(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA29076B1 publication Critical patent/MA29076B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA29925A 2004-11-19 2007-05-22 Préparations pharmaceutiques comprenant un dérivé de camptothécine MA29076B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62975704P 2004-11-19 2004-11-19

Publications (1)

Publication Number Publication Date
MA29076B1 true MA29076B1 (fr) 2007-12-03

Family

ID=35691476

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29925A MA29076B1 (fr) 2004-11-19 2007-05-22 Préparations pharmaceutiques comprenant un dérivé de camptothécine

Country Status (28)

Country Link
US (1) US8518961B2 (fr)
EP (1) EP1814520B1 (fr)
JP (1) JP4982378B2 (fr)
KR (1) KR101283840B1 (fr)
CN (1) CN101056619A (fr)
AR (1) AR052033A1 (fr)
AU (1) AU2005306018B2 (fr)
BR (1) BRPI0518448A2 (fr)
CA (1) CA2584343C (fr)
DK (1) DK1814520T3 (fr)
ES (1) ES2572133T3 (fr)
GT (1) GT200500310A (fr)
HR (1) HRP20160446T1 (fr)
HU (1) HUE027135T2 (fr)
IL (1) IL182703A (fr)
MA (1) MA29076B1 (fr)
MX (1) MX2007005897A (fr)
MY (1) MY148647A (fr)
NO (1) NO342592B1 (fr)
NZ (1) NZ554551A (fr)
PE (1) PE20061077A1 (fr)
PL (1) PL1814520T3 (fr)
RU (3) RU2007122470A (fr)
SI (1) SI1814520T1 (fr)
TN (1) TNSN07193A1 (fr)
TW (1) TWI368521B (fr)
WO (1) WO2006053755A1 (fr)
ZA (1) ZA200703148B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
MX2008001965A (es) * 2005-08-10 2008-03-26 Novartis Ag Composiciones en microparticulas del inhibidor de topoisomerasa i 7-ter-butoxiiminometilcamptotecina.
JP2010508357A (ja) * 2006-10-31 2010-03-18 ワイス エルエルシー ホスホリパーゼ酵素阻害剤の処方
US20100070052A1 (en) * 2008-08-19 2010-03-18 Robb Fujioka System and method for providing applications and peripherals to a fixed price component-based computing platform
MX340819B (es) 2010-06-29 2016-07-26 Poniard Pharmaceuticals Inc * Formulacion oral de inhibidores de quinasa.
CN103168037A (zh) 2010-06-30 2013-06-19 博尼亚德医药品股份有限公司 激酶抑制剂的合成和用途
US12226412B2 (en) 2012-05-25 2025-02-18 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
US8859774B2 (en) 2012-05-25 2014-10-14 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CA3121193C (fr) 2018-12-19 2024-03-12 Corcept Therapeutics Incorporated Formulations pharmaceutiques contenant un relacorilant, un compose azadecaline fusionne avec une heteroarylcetone
JP7688953B2 (ja) * 2021-09-05 2025-06-05 タイレックス， インコーポレーテッド Ｓｎ－３８溶解性及び経口吸収性を向上させた製剤
IL322745A (en) * 2022-08-24 2025-10-01 LYOTROPIC DELIVERY SYSTEMS Ltd Oral administration of active ingredients for the treatment of glycogen storage diseases
KR20250073629A (ko) 2022-10-06 2025-05-27 코어셉트 쎄라퓨틱스 인코포레이티드 글루코코르티코이드 수용체 조절제의 제형
EP4608402A1 (fr) 2022-10-28 2025-09-03 Corcept Therapeutics Incorporated Traitements de la sclérose latérale amyotrophique à l'aide de dazucorilant

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
CA2151491A1 (fr) 1992-12-24 1994-07-07 Robert J. Kaufman Emulsions a base de fluorocarbures
TW406020B (en) 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
US5597829A (en) 1994-05-09 1997-01-28 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin and methods for uses thereof
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
BR9811058A (pt) * 1997-07-29 2000-09-05 Upjohn Co Formulação auto-emulsificante para compostos lipofìlicos
AR013261A1 (es) 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
WO1999056727A2 (fr) 1998-05-07 1999-11-11 Elan Corporation, Plc Systemes d'apport de medicament de preconcentre de microemulsion et d'emulsion depourvues de solvant/cosolvant
US20030059465A1 (en) 1998-05-11 2003-03-27 Unger Evan C. Stabilized nanoparticle formulations of camptotheca derivatives
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
ATE216998T1 (de) * 1999-03-09 2002-05-15 Sigma Tau Ind Farmaceuti Camptothecin-derivate mit antitumor-wirkung
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
MXPA01011981A (es) * 1999-05-24 2003-09-04 Sonus Pharma Inc Vehiculo de emulsion para farmacos poco solubles.
GB9918885D0 (en) 1999-08-10 1999-10-13 Pharmacia & Upjohn Spa Pharmaceutical formulations in hydroxypropymethycellulose capsules
GB9925127D0 (en) 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
US20040009229A1 (en) 2000-01-05 2004-01-15 Unger Evan Charles Stabilized nanoparticle formulations of camptotheca derivatives
GB0001928D0 (en) * 2000-01-27 2000-03-22 Novartis Ag Organic compounds
US20020150615A1 (en) * 2001-02-12 2002-10-17 Howard Sands Injectable pharmaceutical composition comprising microdroplets of a camptothecin
US6653319B1 (en) 2001-08-10 2003-11-25 University Of Kentucky Research Foundation Pharmaceutical formulation for poorly water soluble camptothecin analogues
ES2625340T3 (es) 2001-10-15 2017-07-19 Crititech, Inc. Composiciones y métodos para la administración de fármacos escasamente solubles en agua y métodos de tratamiento
US20060078618A1 (en) 2001-12-11 2006-04-13 Constantinides Panayiotis P Lipid particles and suspensions and uses thereof
JP2003267891A (ja) 2002-03-13 2003-09-25 Mitsubishi-Kagaku Foods Corp Ｗ／ｏ／ｗ型エマルション製剤
CZ294371B6 (cs) 2002-06-10 2004-12-15 Pliva - Lachema, A. S. Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
EP1393719A1 (fr) 2002-08-23 2004-03-03 Munich Biotech AG Compositions à base de carboxylate de camptothécine
JP4426749B2 (ja) 2002-07-11 2010-03-03 株式会社産学連携機構九州 Ｏ／ｗ型エマルション製剤
US20040171560A1 (en) 2002-12-23 2004-09-02 Dabur Research Foundation Stabilized pharmaceutical composition
JP2006199590A (ja) 2003-09-04 2006-08-03 Nano Career Kk 水溶性の塩基性薬物内包ナノ粒子含有組成物
US7223770B2 (en) 2003-10-29 2007-05-29 Sonus Pharmaceuticals, Inc. Tocopherol-modified therapeutic drug compounds
EP1706098A4 (fr) * 2003-11-26 2012-08-15 Supernus Pharmaceuticals Inc Systemes micellaires convenant pour l'apport de composes lipophiles ou hydrophobes
JP5654723B2 (ja) 2003-12-17 2015-01-14 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド カンプトテシン医薬処方物およびその製法
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos

Also Published As

Publication number Publication date
IL182703A (en) 2015-11-30
PE20061077A1 (es) 2006-11-13
SI1814520T1 (sl) 2016-06-30
DK1814520T3 (en) 2016-05-30
MY148647A (en) 2013-05-15
BRPI0518448A2 (pt) 2008-11-18
NO342592B1 (no) 2018-06-18
CA2584343C (fr) 2013-09-24
ZA200703148B (en) 2008-09-25
JP2008520606A (ja) 2008-06-19
HRP20160446T1 (hr) 2016-05-20
AU2005306018A1 (en) 2006-05-26
US8518961B2 (en) 2013-08-27
US20080125450A1 (en) 2008-05-29
KR20070084357A (ko) 2007-08-24
TWI368521B (en) 2012-07-21
HUE027135T2 (en) 2016-08-29
RU2007122470A (ru) 2008-12-27
RU2012120388A (ru) 2013-11-27
KR101283840B1 (ko) 2013-07-15
RU2015131700A (ru) 2017-02-02
WO2006053755A1 (fr) 2006-05-26
NO20072258L (no) 2007-08-10
TNSN07193A1 (en) 2008-11-21
EP1814520B1 (fr) 2016-04-13
MX2007005897A (es) 2007-06-19
EP1814520A1 (fr) 2007-08-08
AU2005306018B2 (en) 2009-12-17
IL182703A0 (en) 2007-09-20
CN101056619A (zh) 2007-10-17
GT200500310A (es) 2006-06-19
RU2620331C2 (ru) 2017-05-24
AR052033A1 (es) 2007-02-28
ES2572133T3 (es) 2016-05-30
NZ554551A (en) 2010-01-29
JP4982378B2 (ja) 2012-07-25
TW200631606A (en) 2006-09-16
PL1814520T3 (pl) 2016-08-31
CA2584343A1 (fr) 2006-05-26

Similar Documents

Publication Publication Date Title
MA29076B1 (fr) Préparations pharmaceutiques comprenant un dérivé de camptothécine
MA28489B1 (fr) Preparations pharmaceutiques
IL177120A0 (en) Formulations for poorly soluble drugs
PT1746976T (pt) Lipossomas úteis para administração de fármacos
DE502004003234D1 (de) Gegen missbrauch gesicherte darreichungsform
DE502004004205D1 (de) Gegen missbrauch gesicherte darreichungsform
DK1615646T4 (da) Farmaceutiske formuleringer, der indeholder methylnaltrexon
DK1615615T3 (da) Manipulationssikre produkter til opioid tilførsel
PL2298766T3 (pl) Preparaty farmaceutyczne zawierające podstawione pochodne pirydyny
GB0426301D0 (en) Pharmaceutical formulations
FR2867064B1 (fr) Doseur de medicaments
DK1753764T3 (da) Pyrrolopyridin-derivater
ATE546141T1 (de) Pharmazeutisches injektionspräparat
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
DK2918286T3 (da) En farmaceutisk formulering
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
EP1819352A4 (fr) Compositions pharmaceutiques a base de carapa guianensis
GB0406048D0 (en) Drug formulations
EP1747205A4 (fr) Compositions pharmaceutiques
DK1729734T3 (da) Spröjtetörrede farmaceutiske præparater
DE112004001429D2 (de) Pharmazeutischer Wirkstoff
FI20040558A0 (fi) Farmaseuttinen valmiste
FI20040146L (fi) Farmaseuttiset valmisteet
DK2298766T3 (da) Farmaceutiske formuleringer omfattende et substitueret pyridinderivat